Atlas Trials

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients

Clinical trial NCT04473716 · COMPLETED

Trial details

NCT number
NCT04473716
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Oral CancerInduction ChemotherapyProgrammed Cell Death 1 InhibitorInductive Therapy
Start date
2020-07-30
Primary completion
2021-04-12
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.